GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » Margin of Safety % (DCF FCF Based)

Hualan Biological Engineering (SZSE:002007) Margin of Safety % (DCF FCF Based) : -353.83% (As of Jun. 09, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2024-06-09), Hualan Biological Engineering's Predictability Rank is 3-Stars. Hualan Biological Engineering's intrinsic value calculated from the Discounted FCF model is ¥14.83 and current share price is ¥17.79. Consequently,

Hualan Biological Engineering's Margin of Safety % (DCF FCF Based) using Discounted FCF model is -353.83%.

Competitive Comparison of Hualan Biological Engineering's Margin of Safety % (DCF FCF Based)

For the Biotechnology subindustry, Hualan Biological Engineering's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hualan Biological Engineering's Margin of Safety % (DCF FCF Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hualan Biological Engineering's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Hualan Biological Engineering's Margin of Safety % (DCF FCF Based) falls into.


Hualan Biological Engineering Margin of Safety % (DCF FCF Based) Calculation

Hualan Biological Engineering's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)=(Intrinsic Value: DCF (FCF Based)-Current Price)/Intrinsic Value: DCF (FCF Based)
=(3.92-17.79)/3.92
=-353.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

Hualan Biological Engineering Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Hualan Biological Engineering's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hualan Biological Engineering (SZSE:002007) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » Margin of Safety % (DCF FCF Based)
Comparable Companies
SZSE:300759 SZSE:002653 SZSE:301301 SZSE:002821 SHSE:688578 SHSE:603233 SHSE:688278 SHSE:688520 SZSE:000403 SZSE:002252 OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
N/A
Address
No. A1 Hualan Avenue, Henan Province, Xinxiang, CHN, 453003
Website
http://www.hualanbio.com
Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.
Executives
An Kang Directors, executives
Pan Ruo Wen Executives
An Wen Qi Executives
Wang Qi Ping Directors, executives
Fan Bei Directors, executives
Ma Xiao Wei Executives
Xie Jun Min Directors, executives
Zhang Bao Xian Executives
Lv Cheng Yu Securities Affairs Representative
Zhang Jin Gang Independent director
Wang Li Ting Independent director
Ma Li Supervisors
Sun Zhen Guo Supervisors
Chen Lei Shan Supervisors
Yang Bao Ping Supervisors

Hualan Biological Engineering (SZSE:002007) Headlines

No Headlines